Prognosis and prognostic factors of patients with mesothelioma: A population-based study

Sjoukje van der Bij, H. Koffijberg, J.A. Burgers, P. Baas, M.J. van de Vijver, B.A.J.M. de Mol, K.G.M. Moons

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)

Abstract

Background: It is important to regularly update survival estimates of patients with malignant mesothelioma as prognosis may vary according to epidemiologic factors and diagnostic and therapeutic management. Methods: We assessed overall (baseline) survival as well as related prognostic variables in a large cohort of 1353 patients with a confirmed diagnosis of malignant mesothelioma between 2005 and 2008.

Results: About 50% of the patients were 70 years or older at diagnosis and the median latency time since start of asbestos exposure was 49 years. One year after diagnosis, 47% of the patients were alive, 20% after 2 years and 15% after 3 years. Prognostic variables independently associated with worse survival were: older age (HR=1.04 per year 95% CI (1.03-1.06)), sarcomatoid subtype (HR=2.45 95% CI (2.06-2.90)) and non-pleural localisation (HR=1.67 95% CI (1.26-2.22)).

Conclusion: Survival of patients with malignant mesothelioma is still limited and depends highly on patient age, mesothelioma subtype and localisation. In addition, a substantial part of the patients had a long latency time between asbestos exposure and diagnosis.

Original languageEnglish
Pages (from-to)161-164
Number of pages4
JournalBritish journal of cancer
Volume107
Issue number1
DOIs
Publication statusPublished - 26 Jun 2012

Fingerprint

Mesothelioma
Population
Survival
Asbestos
Epidemiologic Factors
Malignant Mesothelioma

Keywords

  • Mesothelioma
  • population-based study
  • prognostic factors
  • survival

Cite this

van der Bij, S., Koffijberg, H., Burgers, J. A., Baas, P., van de Vijver, M. J., de Mol, B. A. J. M., & Moons, K. G. M. (2012). Prognosis and prognostic factors of patients with mesothelioma: A population-based study. British journal of cancer, 107(1), 161-164. https://doi.org/10.1038/bjc.2012.245
van der Bij, Sjoukje ; Koffijberg, H. ; Burgers, J.A. ; Baas, P. ; van de Vijver, M.J. ; de Mol, B.A.J.M. ; Moons, K.G.M. / Prognosis and prognostic factors of patients with mesothelioma : A population-based study. In: British journal of cancer. 2012 ; Vol. 107, No. 1. pp. 161-164.
@article{cc9e135bdd504e13affdcd56cee4fdb0,
title = "Prognosis and prognostic factors of patients with mesothelioma: A population-based study",
abstract = "Background: It is important to regularly update survival estimates of patients with malignant mesothelioma as prognosis may vary according to epidemiologic factors and diagnostic and therapeutic management. Methods: We assessed overall (baseline) survival as well as related prognostic variables in a large cohort of 1353 patients with a confirmed diagnosis of malignant mesothelioma between 2005 and 2008.Results: About 50{\%} of the patients were 70 years or older at diagnosis and the median latency time since start of asbestos exposure was 49 years. One year after diagnosis, 47{\%} of the patients were alive, 20{\%} after 2 years and 15{\%} after 3 years. Prognostic variables independently associated with worse survival were: older age (HR=1.04 per year 95{\%} CI (1.03-1.06)), sarcomatoid subtype (HR=2.45 95{\%} CI (2.06-2.90)) and non-pleural localisation (HR=1.67 95{\%} CI (1.26-2.22)).Conclusion: Survival of patients with malignant mesothelioma is still limited and depends highly on patient age, mesothelioma subtype and localisation. In addition, a substantial part of the patients had a long latency time between asbestos exposure and diagnosis.",
keywords = "Mesothelioma, population-based study, prognostic factors, survival",
author = "{van der Bij}, Sjoukje and H. Koffijberg and J.A. Burgers and P. Baas and {van de Vijver}, M.J. and {de Mol}, B.A.J.M. and K.G.M. Moons",
year = "2012",
month = "6",
day = "26",
doi = "10.1038/bjc.2012.245",
language = "English",
volume = "107",
pages = "161--164",
journal = "British journal of cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

van der Bij, S, Koffijberg, H, Burgers, JA, Baas, P, van de Vijver, MJ, de Mol, BAJM & Moons, KGM 2012, 'Prognosis and prognostic factors of patients with mesothelioma: A population-based study' British journal of cancer, vol. 107, no. 1, pp. 161-164. https://doi.org/10.1038/bjc.2012.245

Prognosis and prognostic factors of patients with mesothelioma : A population-based study. / van der Bij, Sjoukje; Koffijberg, H.; Burgers, J.A.; Baas, P.; van de Vijver, M.J.; de Mol, B.A.J.M.; Moons, K.G.M.

In: British journal of cancer, Vol. 107, No. 1, 26.06.2012, p. 161-164.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Prognosis and prognostic factors of patients with mesothelioma

T2 - A population-based study

AU - van der Bij, Sjoukje

AU - Koffijberg, H.

AU - Burgers, J.A.

AU - Baas, P.

AU - van de Vijver, M.J.

AU - de Mol, B.A.J.M.

AU - Moons, K.G.M.

PY - 2012/6/26

Y1 - 2012/6/26

N2 - Background: It is important to regularly update survival estimates of patients with malignant mesothelioma as prognosis may vary according to epidemiologic factors and diagnostic and therapeutic management. Methods: We assessed overall (baseline) survival as well as related prognostic variables in a large cohort of 1353 patients with a confirmed diagnosis of malignant mesothelioma between 2005 and 2008.Results: About 50% of the patients were 70 years or older at diagnosis and the median latency time since start of asbestos exposure was 49 years. One year after diagnosis, 47% of the patients were alive, 20% after 2 years and 15% after 3 years. Prognostic variables independently associated with worse survival were: older age (HR=1.04 per year 95% CI (1.03-1.06)), sarcomatoid subtype (HR=2.45 95% CI (2.06-2.90)) and non-pleural localisation (HR=1.67 95% CI (1.26-2.22)).Conclusion: Survival of patients with malignant mesothelioma is still limited and depends highly on patient age, mesothelioma subtype and localisation. In addition, a substantial part of the patients had a long latency time between asbestos exposure and diagnosis.

AB - Background: It is important to regularly update survival estimates of patients with malignant mesothelioma as prognosis may vary according to epidemiologic factors and diagnostic and therapeutic management. Methods: We assessed overall (baseline) survival as well as related prognostic variables in a large cohort of 1353 patients with a confirmed diagnosis of malignant mesothelioma between 2005 and 2008.Results: About 50% of the patients were 70 years or older at diagnosis and the median latency time since start of asbestos exposure was 49 years. One year after diagnosis, 47% of the patients were alive, 20% after 2 years and 15% after 3 years. Prognostic variables independently associated with worse survival were: older age (HR=1.04 per year 95% CI (1.03-1.06)), sarcomatoid subtype (HR=2.45 95% CI (2.06-2.90)) and non-pleural localisation (HR=1.67 95% CI (1.26-2.22)).Conclusion: Survival of patients with malignant mesothelioma is still limited and depends highly on patient age, mesothelioma subtype and localisation. In addition, a substantial part of the patients had a long latency time between asbestos exposure and diagnosis.

KW - Mesothelioma

KW - population-based study

KW - prognostic factors

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84862984199&partnerID=8YFLogxK

U2 - 10.1038/bjc.2012.245

DO - 10.1038/bjc.2012.245

M3 - Article

VL - 107

SP - 161

EP - 164

JO - British journal of cancer

JF - British journal of cancer

SN - 0007-0920

IS - 1

ER -